Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival.
about
The Nlrp3 Inflammasome Does Not Regulate Alloimmunization to Transfused Red Blood Cells in Mice.Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses.Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice.Red blood cell exchange: 2015 American Society for Apheresis consensus conference on the management of patients with sickle cell disease.Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice.Chronic inflammatory autoimmune disorders are a risk factor for red blood cell alloimmunization.Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.Does recipient inflammation contribute to red blood cell alloimmunization?Molecular immunohaematology round table discussions at the AABB Annual Meeting, Orlando 2016.Complement Component 3 Negatively Regulates Antibody Response by Modulation of Red Blood Cell Antigen.Optimized Antigen-Matched in Sickle Cell Disease Patients: Chances and Challenges in Molecular Times - the Brazilian WaySickle Cell Disease Clinical Trials and Phenotypes
P2860
Q37149950-0DCF7FC4-B9B5-44C7-9109-B0C3A71120E5Q38637406-FEFCFD7C-C141-4786-9B1A-E0B52BB382FFQ38666286-ED88B5F7-6115-4340-B0E6-DBC58FE33B14Q38847491-BD3CD3D3-5452-4D1C-887F-63F78D3193F1Q38949082-485D6A58-CCBE-45FC-AED5-A9E1584C5D31Q40153727-1BB085BC-D6D8-4FDC-B2B9-875D69516D1AQ46865136-73BE8EEF-E28C-4062-9679-C24111B94A50Q47095492-110FBA5B-3D68-4D25-8B1B-F62A06A3C930Q47912617-EFB52327-4FD8-41A5-8965-3C60515BC249Q50283862-20C92EB8-49EC-40BA-A1E9-285ED4B5D6C8Q50437265-6446F7CF-A8DA-4E05-B5BF-87D2E5ACE223Q50442331-C0630BFC-5C5C-4907-A1C6-2E484F2EE653Q51412052-CBC10270-C12E-414D-B8D5-7274EE5F024BQ55252352-5D861306-B69F-421B-A5F4-4F6AE431996DQ57142964-10CD300D-48AE-43E0-B492-7959E2919BA2Q58581652-E1266816-F7E5-4231-93FE-BD37C3BE26B1
P2860
Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Alloimmunization in sickle cel ...... c pain and decreased survival.
@ast
Alloimmunization in sickle cel ...... c pain and decreased survival.
@en
type
label
Alloimmunization in sickle cel ...... c pain and decreased survival.
@ast
Alloimmunization in sickle cel ...... c pain and decreased survival.
@en
prefLabel
Alloimmunization in sickle cel ...... c pain and decreased survival.
@ast
Alloimmunization in sickle cel ...... c pain and decreased survival.
@en
P2093
P2860
P356
P1433
P1476
Alloimmunization in sickle cel ...... c pain and decreased survival.
@en
P2093
Araba Afenyi-Annan
Eugene P Orringer
Marilyn J Telen
Martha R Combs
Melanie E Garrett
P2860
P304
P356
10.1111/TRF.12940
P433
P577
2014-12-01T00:00:00Z